Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
60 studies found for:    Open Studies | "Gastrointestinal Stromal Tumors"
Show Display Options
Rank Status Study
21 Recruiting A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: AUY922
22 Recruiting Regorafenib Post-marketing Surveillance in Japan
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Regorafenib (Stivarga, BAY73-4506)
23 Recruiting Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy
Conditions: Gastrointestinal Stromal Tumor;   Major Gastrectomy
Intervention: Dietary Supplement: cola
24 Recruiting Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST
Condition: Gastrointestinal Stromal Tumor
Interventions: Drug: Sunitinib;   Drug: Regorafenib
25 Recruiting PLX9486 as a Single Agent and in Combination With PLX3397 in Patients With Advanced Solid Tumors
Condition: Gastrointestinal Stromal Tumors
Interventions: Drug: PLX9486;   Drug: PLX3397
26 Not yet recruiting Masitinib vs Placebo - Phase III Study to Compare the Efficacy and Safety of Masitinib to Placebo in Patients With Localized, Primary GIST After Complete Surgery and With High Risk of Recurrence
Condition: Gastro-Intestinal Stromal Tumour
Interventions: Drug: Masitinib;   Drug: Placebo
27 Unknown  A Retrospective Study of C-kit Mutation Status in Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib.
Condition: Asian Patients With Advanced Gastro-intestinal Stromal Tumors (GIST) Treated With Imatinib
Intervention: Procedure: Tumor biopsies
28 Recruiting A Trial of Paclitaxel in Patients With Metastatic or Advanced Gastrointestinal Stromal Tumors (GIST) After Failure to Imatinib and Sunitinib
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: Paclitaxel
29 Recruiting Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor
Conditions: Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Gastrointestinal Stromal Tumor;   Premenopausal
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration;   Procedure: Ultrasonography
30 Not yet recruiting Phase II Study of Continuous Dosing of Regorafenib in Patients With Gastrointestinal Stromal Tumors (GISTs) After Failure of Imatinib and Sunitinib
Condition: Gastrointestinal Stromal Tumors (GISTs)
Intervention: Drug: Regorafenib
31 Recruiting GIST: Assessment of Tumor Mutations and TKI Plasma Exposure
Condition: Gastro-intestinal Stromal Tumor
Interventions: Procedure: Vena puncture for blood collection;   Procedure: Tumor biopsy
32 Recruiting Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST
Condition: Gastrointestinal Stromal Tumor
Intervention: Other: follow up
33 Not yet recruiting The Stop-GIST Trial: Discontinuation of Imatinib in Patients With Oligo-metastatic GIST
Condition: Gastrointestinal Stromal Tumor
Intervention: Other: Discontinuation of imatinib
34 Recruiting A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: dasatinib
35 Recruiting Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation
Condition: Gastrointestinal Stromal Tumour (GIST)
Intervention: Drug: regorafenib
36 Recruiting The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib
Conditions: Colorectal Neoplasms;   Gastrointestinal Stromal Tumors
Interventions: Drug: Esomeprazole 40mg concomitantly;   Drug: Esomeprazole 40mg before;   Drug: Regorafenib 160mg or 120mg
37 Unknown  Caphosol in Oral Mucositis Due to Targeted Therapy
Conditions: Oral Mucositis;   Renal Cell Carcinoma;   Hepatocellular Carcinoma;   Gastrointestinal Stromal Tumors
Interventions: Other: supersaturated calcium-phosphate rinse;   Other: sodium chloride 0.9 %
38 Recruiting A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
Condition: Gastrointestinal Stromal Tumors (GISTs)
Intervention: Drug: Imatinib Mesylate
39 Not yet recruiting Ph II CABOGIST in GIST
Condition: Metastatic Gastrointestinal Stromal Tumor
Intervention: Drug: cabozantinib
40 Recruiting Randomized Trial of Crenolanib in Subjects With D842V Mutated GIST
Condition: Gastrointestinal Stromal Tumors With a D842V Mutation in the PDGFRA Gene.
Interventions: Drug: Crenolanib;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years